What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients? Comment

被引：1
作者：
Silvestris, Nicola [1 ,2 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II Bari, Med Oncol Unit, I-70124 Bari, Italy
[2] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, I-70124 Bari, Italy
来源：
EBIOMEDICINE | 2021年 / 74卷
关键词：
D O I：
10.1016/j.ebiom.2021.103733
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Serological Response to BNT162b2 AntiSars-Cov-2 mRNA Vaccine in Patients with Transfusion Dependent Thalassemia
    Zucano, Stefania
    Tarantini, Francesco
    Vitucci, Angelantonio
    Palma, Antonio
    Campanale, Daniela
    Vimercati, Luigi
    Larocca, Angela Maria Vittoria
    Visceglie, Domenico
    Acquafredda, Amalia
    Tafuri, Silvio
    Musto, Pellegrino
    BLOOD, 2021, 138
  • [32] Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
    Chiara Pellicano
    Roberta Campagna
    Alessandra Oliva
    Giorgia Leodori
    Marzia Miglionico
    Amalia Colalillo
    Ivano Mezzaroma
    Claudio Maria Mastroianni
    Ombretta Turriziani
    Edoardo Rosato
    Clinical Rheumatology, 2022, 41 : 2755 - 2763
  • [33] Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2023, 22 (01): : 15 - 16
  • [34] Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
    Pathum Sookaromdee
    Viroj Wiwanitkit
    Hormones, 2023, 22 : 15 - 16
  • [35] Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
    Pellicano, Chiara
    Campagna, Roberta
    Oliva, Alessandra
    Leodori, Giorgia
    Miglionico, Marzia
    Colalillo, Amalia
    Mezzaroma, Ivano
    Mastroianni, Claudio Maria
    Turriziani, Ombretta
    Rosato, Edoardo
    CLINICAL RHEUMATOLOGY, 2022, 41 (09) : 2755 - 2763
  • [36] BNT162b2 mRNA Vaccine interference with Co-Administration of Tdap Vaccine
    Chilimuri, Sridhar
    Mantri, Nikhitha
    Shrestha, Elina
    Sun, Haozhe
    Gongati, Sudharsan
    Zahid, Maleeha
    Kelly, Paul
    AMERICAN JOURNAL OF CASE REPORTS, 2021, 22
  • [37] Efficacy and toxicity of BNT162b2 vaccine in cancer patients
    Ben-Aharon, I.
    Waldhorn, I.
    Holland, R.
    Peer, A.
    Halberthal, M.
    Goshen-Lago, T. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S1130 - S1130
  • [38] BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
    Rahav, Galia
    Lustig, Yaniv
    Lavee, Jacob
    Benjamini, Ohad
    Magen, Hila
    Hod, Tammy
    Shem-Tov, Noga
    Shmueli, Einat Shacham
    Merkel, Drorit
    Ben-Ari, Ziv
    Halperin, Rebecca
    Indenbaum, Victoria
    Olmer, Liraz
    Huppert, Amit
    Mor, Eytan
    Regev-Yochay, Gili
    Cohen, Carmit
    Wieder-Finesod, Anat
    Levy, Itzchak
    ECLINICALMEDICINE, 2021, 41
  • [39] Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient
    Weinstock-Guttman, Bianca
    Jakimovski, Dejan
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2291 - 2292
  • [40] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
    Dagan, Noa
    Barda, Noam
    Biron-Shental, Tal
    Makov-Assif, Maya
    Key, Calanit
    Kohane, Isaac S.
    Hernan, Miguel A.
    Lipsitch, Marc
    Hernandez-Diaz, Sonia
    Reis, Ben Y.
    Balicer, Ran D.
    NATURE MEDICINE, 2021, 27 (10) : 1693 - +
12345